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Abstract: Seven new monoterpene phenyl ethers, namely micranthumnins A–G (17), were isolated from the stem bark of Illicium 
micranthum (Illiciaceae). Their structures were elucidated by comprehensive spectroscopic analyses including MS, IR, 1D and 2D 
NMR. All compounds were evaluated for their anti-AChE activities. 
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Introduction 
Illicium species, which belong to the only genus of the  
family Illiciaceae, are mainly distributed in East Asia and the 
southeast of North America.1 Twenty eight species (over 60% 
of the family) in Illiciaceae are mainly distributed in southern 
and eastern China, and twelve species of Illicium L. are found 
in Yunnan province.2,3 Phytochemical investigation showed 
that this genus produced monoterpenoids,4 sesquiterpene  
lactones,5–8 diterpenoids,9 triterpenoids,10 lignans and  
neolignans,11–13 which showed various bioactivities, such as 
insecticidal activity,14 cancer chemopreventive activity,15 and 
neurotrophic activity.16–18 Illicium micranthum was a  
poisonous shrub used as a traditional pesticide.3 Previous  
studies on this plant have resulted in the isolation of eight 
secoprezizaane sesquiterpene lactones,5 seven phenylpro-
panoids19 and several other compounds.20 As an on-going 
search for neurotrophic active compounds from natural  
resources, our investigation on I. micranthum led to the  
isolation of seven new monoterpene phenyl ethers (1–7). This 
paper deals with the isolation, structure characterization, and 
anti-AChE activity of these compounds. 
 
Results and Discussion 
A 90% aqueous MeOH extract the stem bark of I. 
micranthum was partitioned between CHCl3 and H2O. The 
CHCl3 solubles were dried and subjected to silica gel, 
Sephadex LH-20 and RP-18 gel column chromatography (CC) 
and semipreparative HPLC to afford seven new compounds. 
The molecular formula of micranthumnin A (1) was 
assigned as C20H28O5 on the basis of HREIMS at m/z 348.1931 
(calcd for 348.1937, [M]+), indicating 7 degrees of unsaturation.
Its IR spectrum showed the presence of aromatic ring (1602, 
1516, 1424 cm–1) and one α,β-conjugated carbonyl (1673  
cm–1). The 1H NMR spectrum of 1 (Table 1) revealed the 
presence of one 1,3,4-trisubstituted aromatic ring [δH 7.03 (1H, 
d, J = 1.8 Hz, H-2), 6.91 (1H, d, J = 8.4 Hz, H-5), 6.87 (1H, 
dd, J = 8.4, 1.8 Hz, H-6)], one methoxy group at δH 3.84 (3H, s, 
OCH3-3), four methyls [δH 1.12 (3H, d, J = 6.6 Hz, H-9), 1.91 
 
Figure 1.  Structures of compounds 1–7, 1a and 2a 
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(3H, d, J = 1.2 Hz, H-8′), 2.13 (3H, d, J = 1.2 Hz, H-9′), 1.72 
(3H, s, H-10′)], two olefinic protons at [δH 5.61 (1H, td, J = 6.6, 
1.2 Hz, H-2′), 6.22 (1H, br. s, H-6′)], and two oxymethines [δH 
4.43 (1H, d, J = 4.8 Hz, H-7), 3.84 (1H, m, H-8)]. The proton 
and carbon signals were assigned from the 1H-1H COSY, 
HMQC and HMBC spectroscopic data (see Table 1). 
Comparison of the NMR data between 1 and tomentellin21 
revealed that compound 1 was structurally similar to 
tomentellin21. The difference was the methyl ether moiety at δC 
166.8 (C-7′), 52.0 (OCH3-7′) in tomentellin21 was replaced by 
a 1,2-propanediol moiety at δC 77.4 (C-7), 71.3 (C-8), and 17.5 
(C-9) in 1. This was further confirmed by the HMBC 
correlations (Figure 2) from H-7 at δH 4.43 to C-1 (δC 133.2), 
C-2 (δC 109.9), C-6 (δC 118.9). Moreover, the HMBC 
correlation from H-1′ at δH 4.61 to C-4 (δC 147.6), combined 
with the ROESY correlations (Figure 4) of H-1′/H-5 and -
OCH3/H-2 suggested that the monoterpene moiety was 
connected to C-4 of the aromatic ring through an ether bond. 
The E-zeometry at C-2′ and C-3′ was assigned by the ROESY 
correlations of H-2′/H-4′ and H-1′/H-10′. 
Micranthumnin B (2) was obtained as a yellow gum with 
the same molecular formula as 1. Its 13C NMR spectrum 
(Table 3) was very similar to that of 1 except the signals of  
C-7, C-8, and C-9 shifted from δC 77.4, 71.3 and 17.5 to δC 
79.2, 72.1 and 18.7, respectively. Moreover, the 1H NMR 
signals (Table 1) of H-7, H-8 and H-9 shifted from δH 4.43, 
3.84 and 1.12 to δH 4.28, 3.77, 0.96. Detailed analysis of 2D 
NMR spectra revealed that the structure of 2 was also 4- 
[(2′E)-3′,7′-dimethyl-5′-oxo-2′,6′-octadienyl)oxy]-3-methoxy-
phenylpropane-7,8-diol. The similarity of the NMR spectra 
between 1 and 2 suggested that they might be erythro and 
threo isomers. The OH configurations of two stereogenic 
centers in compounds 1 and 2 were deduced by comparison 
with the 13C NMR spectra of similar compounds, erythro- and 
threo-1-phenyl-1,2-dihydroxypropane, for which the structures 
were confirmed by synthesis22,23. The 13C NMR signals of C-7 
and C-8 in erythro-1-phenyl-1,2-dihydroxypropane (δC 77.6 
and 71.3) were closer together than those in the threo isomer 
(δC 79.5 and 72.7). In compound 1, C-7 and C-8 showed 
signals at δC 77.4 and 71.3, which were closer than those of 
compound 2 (δC 79.2 and 72.1). 
The relative configurations of 1 and 2 were further 
confirmed by the derivative reaction. In the reactions, the 
vicinal diol parts in 1 and 2 react with DMP to yield ketal 
products 1a and 2a, respectively, which makes the carbon-
carbon bond between C-7 and C-8 rotate unfreely. The relative 
configurations of 1 and 2 were determined depending on the 
two ketal products 1a and 2a whose relative configurations 
were clarified by ROESY experiments (Figure 3). ROESY 
correlations of H-7/H-1′′ and H-8/H-1′′ were detected while 
the correlation of H-7/H-9 was disappeared in 1a, which 
determined the erythro configuration of 1a. The relative 
configuration of 2a was determined to be threo by ROESY 
correlations of H-7/H-1′′, H-8/H-3′′, and H-7/H-9. 
Consequently, the relative configurations of 1 and 2 were 
determined to be erythro and threo, respectively (Figure 1). 
The mass spectrum of compound 3 (HREIMS m/z 362.2098, 
clacd for 362.2093, [M]+) was 14 amu higher than that of 1, 
indicating that there was probably one more methyl group in 3. 
The similarities of the spectroscopic data (Tables 2 and 3) 
between 3 and 1 suggested that 3 was identical to 1 except for 
the methoxyl group at C-7, causing a significant downfield 
chemical shift from δC 77.4 to δC 89.2 due to C-7. HMBC 
correlation (Figure 2) from OCH3-7 at δH 3.23 to C-7 at δC 
89.2 further confirmed the above assignment. Without an 
isomer as a comparison, as well as the significant difference of 
C-7 chemical shift between 3 and 1, the relative configuration 
of 3 was not clarified. Finally, the structure of 3 was 
established as shown in Figure 1, and named as 
micranthumnin C.  
Micranthumnin D (4), yellow gum, had the same molecular 
formula (C20H28O5) as 1. Analysis of its NMR data (Tables 2 
and 3) showed that 4 was similar to 1, except for the signals of 
one methylene, one oxymethylene, one olefinic methine and 
Table 1. 1H NMR (600 MHz) data of compounds 1 and 2 in 
CD3OD (δ in ppm, J in Hz) 
pos. 1 2 
2 7.03 (d, 1.8) 6.98 (d, 1.8) 
5 6.91 (d, 8.4) 6.91 (d, 8.4) 
6 6.87 (dd, 8.4, 1.8) 6.86 (dd, 8.4, 1.8) 
7 4.43 (d, 4.8) 4.28 (d, 7.2) 
8 3.84 (overlapped) 3.77 (dq, 7.2, 6.6) 
9 1.12 (d, 6.6) 0.96 (d, 6.6) 
1′ 4.61 (d, 6.6) 4.62 (d, 6.6) 
2′ 5.61 (td, 6.6, 1.2) 5.60 (td, 6.6, 1.2) 
4′ 3.16 (s) 3.16 (s) 
6′ 6.22 (br. s) 6.22 (br. s) 
8′ 1.91 (d, 1.2) 1.90 (d, 1.2) 
9′ 2.13 (d, 1.2) 2.13 (d, 0.6) 
10′ 1.72 (s) 1.71 (s) 
OCH3-3 3.84 (s) 3.84 (s) 
 
Figure 3.  Selected ROESY correlations of 1a and 2a 
 
Figure 2.  Selected 1H-1H COSY and HMBC correlations of 1, 
3, 4, 6 and 7 
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one quaternary carbon shifted from δC 55.0 (C-4′), 65.6 (C-1′), 
124.5 (C-2′), 134.7 (C-3′) to δC 41.6, 68.4, 128.4, 155.9, 
suggesting that the double bond between C-2′ and C-3′ may 
have migrated. 1H-1H COSY, HSQC and HMBC analyses of 4 
showed the presence of a CH2 (C-1′)-CH2 (C-2′) unit. HMBC 
correlations (Figure 2) from H-2′ at δH 2.65 to C-1′, C-3′, C-4′ 
and from H-4′ at δH 6.25 to C-3′, C-5′ indicated the presence of 
a trisubstituted double bond between C-3′ and C-4′. The E-
geometry was established by the ROESY correlation (Figure 4) 
of H-4′/H-2′. Consequently, the structure of 4 was established 
as shown in Figure 1 and named as micranthumnin D. 
Micranthumnin E (5) showed an [M]+ ion at m/z 348.1932 
(calcd for 348.1937) in the HREIMS spectrum, indicating a 
molecular formula of C20H28O5. HMBC correlations in 
combination with HSQC and 1H-1H COSY spectra indicated 
that 5 had the same planar structure as 4. A significant 
chemical shift of C-2′ (δC 34.9) and C-10′ (δC 26.9) might 
suggest a different geometry of the double bond between C-3′ 
and C-4′. ROESY correlation (Figure 4) of H-4′/H-10′ was 
observed, which was absent in 4, while correlation of H-2′/H-
4′ disappeared in 5, indicating a Z-geometry double bond 
between C-3′ and C-4′. The chemical shifts of C-7 and C-8 in 
4 and 5 were very similar (4, δC 80.1, 73.0; 5, δC 80.2, 73.0), 
and both similar to the threo-1-phenyl-1,2-dihydroxypropane 
(δC 79.5, 72.7). Consequently, the relative configurations of 4 
and 5 were established as shown in Figure 1. 
The molecular formula of 6 was determined as C18H22O4 by 
HREIMS (m/z 302.1512, calcd for 302.1518, [M]+). 
Comparison of its NMR data (Tables 2 and 3) with 1 
suggested that the 1,2-propanediol group in 1 was replaced by 
a formyl group at C-1. The HMBC correlations (Figure 2) 
from H-7 (δH 9.83) to C-1 (δC 131.5), C-2 (δC 110.7), and C-6 
(δC 127.7), from H-2 (δH 7.47) and H-6 (δH 7.54) to C-7 (δC 
192.9) further confirmed this assignment. Thus, 6 was 
determined and named as micranthumnin F.  
The mass spectrum showed that compound 7 was 34 mass 
amu lower than that of 1, indicating the probable loss of two 
hydroxyl groups in 7. The NMR data indicated that 7 was 
similar to 1. Extensive analyses of its 1D and 2D NMR data 
suggested that the 1,2-propanediol group in 1 was replaced by 
a propenyl group. The signals corresponding to a propenyl 
group at δH 6.32 (1H, dq, J = 15.6, 1.2 Hz, H-7), 6.13 (1H, dq, 
J = 15.6, 6.6 Hz, H-8), and 1.85 (3H, dd, J = 6.6, 1.2 Hz, H-9) 
were evident in the 1H NMR data (Table 2) of 7. The structure 
was further confirmed by HMBC correlations (Figure 2) of H-
7/C-1, C-2, C-6 and H-8/C-1, C-9. Moreover, the analysis of 
the ROESY spectrum as well as the coupling constant (J = 
15.6 Hz) between H-7 and H-8, indicating an E-geometry 
double bond. Therefore, the structure of 7 was determined and 
named as micranthumnin G. 
The acetyl cholinesterase (AChE) inhibitory activities of all 
compounds were assayed using the Ellman method.24  
Compound 5 showed weak inhibitory activity (27.4%) at a 
concentration of 50 μM, using tacrine (0.33 μM) as the  
positive control (50.56% inhibition). The remaining com-
pounds were inactive at 50 μM. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a JASCO P-1020 polarimeter. IR and UV spectra 
were recorded on a Bruker Tensor 27 FT-IR spectrometer and 
a Shimadzu UV2401PC spectrometer, respectively. 1D and 2D 
NMR spectra were recorded on Bruker Avance Ⅲ-600, DRX-
500 or AM-400 MHz spectrometers with TMS as internal 
standard at room temperature. HRESIMS were recorded on a 
Table 2. 1H NMR data of compounds 3–7 (δ in ppm, J in Hz) 
pos. 3b 4a 5a 6a 7a 
2 6.79 (s) 7.01(d, 2.4) 6.97(d, 1.8) 7.47 (d, 1.8) 6.96 (d, 1.8) 
5 6.85 (d, 8.3) 6.96 (d, 8.4) 6.95 (d, 8.4) 7.15 (d, 8.4) 6.84 (d, 8.4) 
6 6.78 (d, 8.3) 6.90 (dd, 8.4, 2.4) 6.86 (dd, 8.4, 1.8) 7.54 (dd, 8.4, 1.8) 6.82 (dd, 8.4, 1.8) 
7 3.77 (d, 8.0) 4.31 (d, 7.2) 4.28 (d, 7.2) 9.83 (s) 6.32 (dq, 15.6, 1.2) 
8 3.80 (overlapped) 3.81 (overlapped) 3.80 (overlapped)  6.13 (dq, 15.6, 6.6) 
9 0.96 (d, 5.6) 0.98 (d, 6.0) 0.96 (d, 6.6)  1.85 (dd, 6.6, 1.2) 
1′ 4.66 (d, 6.0) 4.18 (t, 6.6) 4.16 (t, 6.6)  4.78 (d, 6.0) 4.61 (d, 6.0) 
2′ 5.64 (t, 6.0) 2.65 (t, 6.6) 3.05 (t, 6.6) 5.64 (t, 6.0) 5.60 (td, 6.0, 1.2) 
4′ 3.14 (s) 6.25 (d, 1.2) 6.23 (d, 0.6) 3.21(s) 3.14 (s) 
6′ 6.11 (br. s) 6.17 (br. s) 6.17 (br. s) 6.23 (br. s) 6.18 (br. s) 
8′ 1.88 (s) 1.94 (d, 1.2) 2.14 (d, 1.2) 1.91 (s) 1.87 (d, 1.2) 
9′ 2.14 (s) 2.16 (d, 1.2) 1.91 (d, 1.2) 2.15 (s) 2.12 (d, 1.2) 
10′ 1.75 (s) 2.23 (d, 1.2) 2.04 (d, 0.6) 1.79 (s) 1.71 (s) 
OCH3-3 3.88 (s) 3.85 (s) 3.82 (s) 3.92 (s) 3.83 (s) 
OCH3-7 3.23 (s)     
aRecorded in CD3OD at 600MHz; bRecorded in CDCl3 at 400MHz. 
 
Figure 4.  Selected ROESY correlations of 1, 4 and 5 
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API QSTAR Pulsar 1 spectrometer. Column chromatography 
(CC) was performed on silica gel (100200 mesh, Qingdao 
Marine Chemical Ltd., Qingdao, China), Sephadex LH-20 
(Amersham Biosciences, Sweden) and RP-18 gel (40 × 75 μm, 
Fuji Silysia Chemical Ltd., Japan). Analytical and semiprepar-
ative HPLC were performed on SHIMADZU LC-20AT  
system equipped with Extend-C18 column (4.6 × 150 mm) and 
YMC-Pack ODS-A column (10 × 150 mm). 
 
Plant Material. Stem bark of I. micranthum were collected 
in Dongchuan of Yunnan province, China, in May 2011. The 
plant material was identified by Dr. Rong Li of Kunming  
Institute of Botany, Chinese Academy of Sciences. A sample 
was deposited in our laboratory. A voucher specimen of I. 
micranthum (Li Rong 560) is deposited in State Key  
Laboratory of Phytochemistry and Plant Resources in West 
China, Kunming Institute of Botany, Chinese Academy of 
Sciences. 
 
Extraction and Isolation. The air-dried stem bark of I. 
micranthum (14 kg) was powdered and extracted with MeOH 
(3 × 25 L) at room temperature, and concentrated in vacuo to 
give a crude extract. The extract was successively fractionated 
with CHCl3 and EtOAc. A portion of the CHCl3 extract (310 g) 
was separated by silica gel column chromatography, using 
CHCl3/MeOH (20:1 to 2:1) as a gradient solvent system to 
afford fractions I–VI.  
Fraction II was isolated by silica gel eluting with a gradient 
of petroleum ether/EtOAc (40:1, 20:1, 10:1, 5:1, to 2:1) to 
afford four subfractions (A1–A4). Fraction A2 was chromato-
graphed over Sephadex LH-20 with MeOH to yield 7 (31 mg). 
Fraction III was subjected to RP-18 column chromatography 
(MeOH/H2O, 30:70 to 80:20) to afford three fractions. The 
first fraction was chromatographed over Sephadex LH-20 with 
MeOH and applied to silica gel CC (eluted with 
CHCl3/Me2CO, 40:1), and then purified by semipreparative 
HPLC to give 1 (15 mg, tR 21.5 min, MeCN/H2O 39:61), and 2 
(40 mg, tR 25.0 min, MeCN/H2O 39:61), respectively. The 
second fraction was subjected to silica gel CC using 
CHCl3/Me2CO (40:1), with final purification by semiprepara-
tive HPLC (MeCN/H2O 45:55), to give 4 (3.5 mg, tR 17.0 min) 
and 5 (42 mg, tR 23.0 min). Compound 3 (3.2 mg) was  
obtained from the last fraction after repeated silica gel CC and 
Sephadex LH-20 CC, followed by semipreparative HPLC (tR 
38.0 min, MeOH/H2O 70:30). Fraction IV was subjected to 
repeated silica gel CC (petroleum ether/Me2CO, 95:5 to 4:1), 
to afford seven subfractions (B1–B7). Fraction B4, eluted with 
MeOH over Sephadex LH-20, was further separated on  
semipreparative HPLC to yield 6 (4.5 mg, tR 18.5 min, 
CH3OH/H2O 70:30). 
 
Micranthumnin A (1): yellow gum; [α]21D   – 7.9 (c 0.13, 
MeOH); UV (MeOH) λmax (log ε) 233 (2.31), 204 (2.55) nm; 
IR νmax (KBr) 3443, 2965, 2900, 1673, 1602, 1516, 1424, 1262, 
1228, 1137, 994, 854, 621 cm–1; 1H (600 MHz, CD3OD) and 
13C NMR (100 MHz, CDCl3) data, see Tables 1 and 3; 
HREIMS: m/z 348.1931 [M]+, (clacd for C20H28O5, 348.1937). 
 
Micranthumnin B (2): yellow gum; [α]21D   – 7.6 (c 0.17, 
MeOH); UV (MeOH) λmax (log ε) 233 (2.27), 204 (2.52) nm; 
IR νmax (KBr) 3424, 2973, 2933, 2912, 1685, 1617, 1513, 1448, 
1262, 1225, 1138, 1035, 809, 624 cm–1; 1H (600 MHz, CD3OD) 
and 13C NMR (100 MHz, CDCl3) data, see Tables 1 and 3; 
HREIMS: m/z 348.1925 [M]+, (clacd for C20H28O5, 348.1937). 
 
Table 3. 13C NMR data of compounds 1–7 (δ in ppm) 
Pos. 1b 2b 3b 4a 5a 6a 7b 
1 133.2 s 133.9 s 131.0 s 136.9 s 136.4 s 131.5 s 131.3 s 
2 109.9 d 109.9 d 110.0 d 112.4 d 112.1 d 110.7 d 108.7 d 
3 149.4 s 149.4 s 149.5 s 151.0 s 150.8 s 151.3 s 149.4 s 
4 147.6 s 147.7 s 148.0 s 149.2 s 149.3 s 155.3 s 147.0 s 
5 112.9 d 112.9 d 112.6 d 115.0 d 114.3 d 113.5 d 113.2 d 
6 118.9 d 119.1 d 120.3 d 120.9 d 120.9 d 127.7 d 118.5 d 
7 77.4 d 79.2 d 89.2 d 80.1 d 80.2 d 192.9 d 130.5 d 
8 71.3 d 72.1 d 71.3 d 73.0 d 73.0 d  123.8 d 
9 17.5 q 18.7 q 18.0 q 19.4 q 19.4 q  18.3 q 
1′ 65.6 t 65.6 t 65.6 t 68.4 t 69.1 t 66.6 t 65.6 t 
2′ 124.5 d 124.5 d 124.5 d 41.6 t 34.9 t 125.1 d 124.7 d 
3′ 134.7 s 134.7 s 134.8 s 155.9 s 157.1 s 137.0 s 134.6 s 
4′ 55.0 t 54.9 t 55.0 t 128.4 d 128.6 d 55.6 t 55.1 t 
5′ 198.2 s 198.3 s 198.2 s 193.8 s 193.0 s 200.5 s 198.3 s 
6′ 122.7 d 122.7 d 122.7 d 127.3 d 127.1 d 123.8 d 122.7 d 
7′ 156.5 s 156.6 s 156.4 s 156.8 s 156.9 s 158.4 s 156.5 s 
8′ 27.7 q 27.7 q 27.7 q 27.9 q 27.9 q 27.7 q 27.7 q 
9′ 20.7 q 20.7 q 20.7 q 20.9 q 20.9 q 20.9 q 20.7 q 
10′ 16.9 q 16.9 q 16.9 q 19.6 q 26.9 q 17.1 q 16.9 q 
OCH3-3 55.8 q 55.8 q 55.9 q 56.6 q 56.5 q 56.4 q 55.7 q 
OCH3-7   56.5 q     
aRecorded in CD3OD at 150MHz; bRecorded in CDCl3 at 100MHz. 
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Micranthumnin C (3): yellow gum; [α]21D   – 20.2 (c 0.08, 
MeOH); UV (MeOH) λmax (log ε) 233 (2.21), 204 (2.47) nm; 
IR νmax (KBr) 3441, 2968, 2932, 1687, 1620, 1513, 1449, 1261, 
1138, 1034, 975 cm–1; 1H (600 MHz, CD3OD) and 13C NMR 
(100 MHz, CDCl3) data, see Tables 2 and 3; HREIMS: m/z 
362.2098 [M]+, (clacd for C21H30O5, 362.2093). 
 
Micranthumnin D (4): yellow gum; [α]24D   + 7.6 (c 0.10, 
MeOH); UV (MeOH) λmax (log ε) 268 (2.23), 203 (2.40) nm; 
IR νmax (KBr) 3431, 2970, 2931, 1668, 1627, 1514, 1263, 1138, 
1034, 871, 624 cm–1; 1H (600 MHz) and 13C NMR (150 MHz) 
data (CD3OD), see Tables 2 and 3; HREIMS: m/z 348.1937 
[M]+, (clacd for C20H28O5, 348.1937). 
 
Micranthumnin E (5): yellow gum; [α]24D   – 13.6 (c 0.09, 
MeOH); UV (MeOH) λmax (log ε) 268 (2.28), 203 (2.46) nm; 
IR νmax (KBr) 3425, 2971, 2933, 1669, 1626, 1515, 1263, 1138, 
1033, 872, 769 cm–1; 1H (600 MHz) and 13C NMR (150 MHz) 
data (CD3OD), see Tables 2 and 3; HREIMS: m/z 348.1932 
[M]+, (clacd for C20H28O5, 348.1937). 
 
Micranthumnin F (6): colorless gum; [α]21D   – 7.4 (c 0.20, 
MeOH); UV (MeOH) λmax (log ε) 230 (2.37), 205 (2.32) nm; 
IR νmax (KBr) 3426, 2936, 1684, 1586, 1508, 1424, 1267, 1136, 
991, 731 cm–1; 1H (600 MHz, CD3OD) and 13C NMR (150 
MHz, CDCl3) data, see Tables 2 and 3; HREIMS: m/z 
302.1512 [M]+, (clacd for C18H22O4, 302.1518). 
 
Micranthumnin G (7): colorless gum; [α]21D   – 3.9 (c 0.31, 
MeOH); UV (MeOH) λmax (log ε) 253 (2.32), 210 (2.47) nm; 
IR νmax (KBr) 2933, 2913, 1686, 1618, 1511, 1446, 1262, 1225, 
1137, 964 cm–1; 1H (400 MHz) and 13C NMR (100 MHz) data 
(CDCl3), see Tables 2 and 3; HREIMS: m/z 314.1887 [M]+, 
(clacd for C20H26O3, 314.1882). 
 
Derivative Reaction. 1 [9 mg, 0.026 mmol in DMP (1 mL)] 
and 2 [10 mg, 0.029 mmol in DMP (1 mL)] were stirred with 
PPTs (1 mg), respectively, and protected with argon at room 
temperature for 24 hours. 
 
Anti-AChE Assay. AChE inhibitory activities of the  
compounds isolated were assayed by the spectrophotometric 
method developed by Ellman et al.11 Acetylthiocholine iodide 
(Sigma) was used as substrate in the assay. Compounds were 
dissolved in DMSO. The mixture contained 110 μL phosphate 
buffer (pH 8.0), 10 μL of test compound solution (50 μM), and 
40 μL AChE solution (0.04 U/100 μL), and the mixture was 
incubated for 20 min (30 °C). The reaction was initiated by the 
addition of 20 μL of DTNB (6.25 mM) and 20 μL of  
acetylthiocholine iodide (6.25 mM). The hydrolysis of 
acetylthiocholine was monitored at 405 nm after 30 min.  
Tacrine was used as positive control. All the reactions were 
performed in triplicate. The percentage inhibition was  
calculated as follows: % inhibition = (E – S)/E × 100 (E is the 
activity of the enzyme without test compound and S is the 
activity of enzyme with test compound). 
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